Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“The Allspring Emerging Markets Equity Advantage Fund outperformed its benchmark in Q3 2025, returning 10.98% versus 10.64% for the MSCI Emerging Markets Index. The fund benefited...” | Q3 2025 Sep 30, 2025 | Preview | |
“Reported a second-quarter fiscal 2026 earnings beat driven by better-than-expected credit costs and improving asset quality. Shares re-rated post...” | Q4 2025 Dec 31, 2025 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $SHRIRAMFIN.NS.
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
